Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation &
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
August
29, 2008
-
Cyber Letters
(updated)
-
Medical, Statistical, and
Clinical Pharmacology Reviews of
Pediatric Studies
(updated)
-
Natural Disaster Response
(updated)
-
New
and Generic Drug Approvals
-
Galantamine Hydrobromide
Tablets, Alphapharm Party,
Ltd., Approval
-
Galantamine Hydrobromide
Tablets, Barr Laboratories,
Inc., Approval
-
Glucophage
(metformin hydrochloride)
Tablets, Bristol-Myers
Squibb Co., Labeling
Revision
-
Glucophage XR
(metformin hydrochloride)
Extended-Release Tablets,
Bristol-Myers Squibb Co.,
Labeling Revision
-
Sandostatin
(octreotide acetate)
Injection, Novartis
Pharmaceuticals Corp.,
Labeling Revision
-
Zemuron
(rocuronium bromide)
Injection, Organon USA,
Inc., Patient Population
Altered
August
28, 2008
-
New
and Generic Drug Approvals
-
Estring
(estradiol) Extended-Release
Vaginal Insert, Pharmacia &
Upjohn Co., Labeling
Revision
-
Invega
(paliperidone)
Extended-Release Tablets,
Johnson & Johnson
Pharmaceutical Research &
Development, LLC,
Manufacturing Change or
Addition
-
Metadate CD
(methylphenidate
hydrochloride)
Extended-Release Capsules,
UCB, Inc., Labeling Revision
-
NovoLog Mix 50/50
(insulin aspart protamine
and insulin aspart)
Injectable Suspension, Novo
Nordisk, Inc., Approval
-
Radiogardase (Prussian Blue)
(ferric hexacyanoferrate(II))
Capsules, Heyl
Chemisch-Pharmazeutische
Fabrik GmbH & Co., Package
Change
August
27, 2008
August
26, 2008
August
25, 2008
-
FDA
updates the Information for
Healthcare Professionals sheet
for Tysabri (natalizumab).
-
New
and Generic Drug Approvals
-
Amicar
(aminocaproic acid) Oral
solution, Xanodyne
Pharmaceuticals, Inc.,
Labeling Revision
-
Amicar
(aminocaproic acid) Tablets,
Xanodyne Pharmaceuticals,
Inc., Labeling Revision
-
Ceftriaxone
(ceftriaxone sodium)
Injection, Bedford
Laboratories, Approval
-
Losartan Potassium
Tablets, Aurobindo Pharma,
Ltd., Tentative Approval
-
Metaglip
(glipizide and metformin
hydrochloride) Tablets,
Bristol-Myers Squibb Co.,
Labeling Revision
-
Mucinex
(guaifenesin)
Extended-Release Tablets,
Adams Respiratory
Therapeutics, Package Change
-
Pamidronate Disodium
Injection, Pliva-Lachema,
AS, Approval
-
Qvar 40
(beclomethasone dipropionate)
Inhalation Aerosol, Teva
Global Regulatory Research,
LLC, Labeling Revision
-
Qvar 80
(beclomethasone dipropionate)
Inhalation Aerosol, Teva
Global Regulatory Research,
LLC, Labeling Revision
-
Rocephin
(ceftriaxone sodium)
Injection, HLR Technology
Corp., Labeling Revision
-
Rocephin Kit
(ceftriaxone sodium and
lidocaine) Injection, HLR
Technology Corp., Labeling
Revision
-
Somavert
(pegvisomant) Injection,
Pharmacia & Upjohn, Labeling
Revision
-
Sustiva
(efavirenz) Capsules,
Bristol-Myers Squibb Co.,
Labeling Revision
-
Sustiva
(efavirenz) Tablets,
Bristol-Myers Squibb Co.,
Labeling Revision
-
Vidaza
(azacitidine) Subcutaneous
I.V. Injection, Celgene
Corp., Efficacy Supplement
with Clinical Data to
Support
CDER Drug Links
|
CBER Links
|
| August 29, 2008 |
 |
Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Request for Inspection Under the Inspection by Accredited Persons Program   |
| |
| August 28, 2008 |
 |
Federal Register: Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications   |
 |
Class I Medical Device Recall: Pacific Consolidated Industries LLC, Mobile Oxygen Storage Tank  |
| |
| August 27, 2008 |
 |
Summary Information for: Attain StarFix Model 4195 Lead  |
| |
| August 26, 2008 |
 |
Summary Information for: T-SPOT-TB  |
| |
| August 25, 2008 |
 |
Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions (Form FDA 3674)   |
 |
Federal Register: FDA Regulations; Technical Amendment   |
 |
PMA Final Decisions for July 2008  |
| |
|
|
|
|
Medical Device Links
|
This
Week
Rule Changes:
16,
610, 640, 812, 814, 822, and
860 |
|
Friday,
August 29, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
5097650977 [E820113]
[TEXT] [PDF]
|
|
Thursday,
August 28, 2008 |
NOTICES
Integrated Summary of
Effectiveness; Draft
Guidance for Industry;
Availability,
5082550826 [E819906]
[TEXT] [PDF]
Medical Devices:
Premarket
Approval Applications;
Availability of Safety and
Effectiveness Summaries,
5082650827 [E819907]
[TEXT] [PDF]
|
|
Wed.,
August 27, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
5062850630 [E819843]
[TEXT] [PDF]
|
|
Tuesday,
August 26, 2008 |
|
NONE
|
|
Monday,
August 25, 2008 |
|
RULES
FDA Regulations; Technical
Amendment,
4994149943 [E819654]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
5002450028 [E819625]
[TEXT] [PDF]
5002850030 [E819626]
[TEXT] [PDF]
5003150032 [E819627]
[TEXT] [PDF]
5003050031 [E819653]
[TEXT] [PDF]
Over the Counter Cough and
Cold Medications for
Pediatric Use; Notice of
Public Hearing,
5003350036 [E819657]
[TEXT] [PDF]
|
|
|
|
.jpg)



EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|